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ABSTRACT
Purpose To compare six commonly available silicates for their
suitability to develop tablets by adsorbing components of liquid
lipid-based drug delivery systems.
Methods The tabletability of Aerosil® 200, Sipernat® 22, Sylysia®
350, Zeopharm® 600, Neusilin® US2 and Neusilin® UFL2 were
studied by compressing each silicate into tablets in the presence of
20% microcrystalline cellulose and measuring the tensile strength of
tablets produced. Three components of lipid based formulations,
namely, Capmul® MCM EP (glycerol monocaprylocaprate),
Captex® 355 EP/NF (caprylic/capric triglycerides) and
Cremophor® EL (PEG-35 castor oil), were adsorbed individually
onto the silicates at 1:1w/w, and themixtureswere then compressed
into tablets. The SEM photomicrographs of neat silicates and their 1:1
w/w mixtures (also 1:2 and 1:3 for Neusilin® US2 and Neusilin®
UFL2) with one of the liquids (Cremophor® EL) were recorded.
Results Neat Aerosil® 200, Sipernat® 22 and Sylysia® 350 were
non-tabletable to the minimum acceptable tensile strength of 1 MPa,
and they were also non-tabletable in presence of liquid. While
Zeopharm® 600, Neusilin® US2 and Neusilin® UFL2 were
tabletablewithout the addition of liquids, onlyNeusilin®US2 retained
acceptable tabletability with 1:1 liquid. The SEM images of silicate-
liquid mixtures indicated that, except for Neusilin®US2, much of the
adsorbed liquid distributed primarily at the surface of particles rather
than inside pores, which hindered their compaction into tablets.
Conclusion Among the six silicates studied, Neusilin® US2
was the only silicate able to produce tablets with acceptable
tensile strength in presence of a lipid component at 1:1 w/w
ratio due to the fact that the liquid was mostly adsorbed into the
pores of the silicate rather than at the surface.
KEY WORDS adsorption . comparative evaluation . lipid .
Neusilin®US2 . SEM images . silicate . surfactant . tablet .
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INTRODUCTION
There has been a great interest in the pharmaceutical field in the
use of silicates for the development of oral dosage forms, espe-
cially to enhance dissolution rate and bioavailability of poorly
water soluble drugs by adsorbing them onto silicates in amor-
phous forms or as solutions (1–8). Having high surface area and
commonly being porous, silicates are capable of adsorbing
liquids, often as much as 2 to 3 times their own weights. They
were first utilized by Jarowski et al. (9) for adsorbing organic
solutions of poorly water-soluble drugs, and, in more recent
years, they were investigated for adsorbing self-emulsifying drug
delivery systems to convert them into dry powders (10–14).
However, such a formulation approach often led to the devel-
opment of powder-filled hard gelatin capsule formulations as the
silicates were inherently non-compactible or the loading of
liquids prevented their compression into tablets (15). The
amount of materials that could be delivered in a unit dose of
capsule was limited to a relatively low maximum amount of
about 300–400 mg of powder for a capsule suitable for oral
administration. On the other hand, as much as 1 g or even a
higher amount of powder may be compressed into a unit tablet.
Considering a tablet weight of 1 g and the liquid to silica ratio of
1:1, this would lead to a tablet with 500mg of liquid component,
which is not possible in a powder-filled capsule.
Despite obvious advantages of tablet formulations, there
are only limited studies on the development of tablet dosage
forms for lipid-based drug delivery systems reported in the
literature. The poor tabletability of powders loaded with
liquid lipids and surfactants into tablets has been the major
development issue. Sander and Holm (3) reported that when
the liquid-loaded powders are compressed, there is a lack
of tablet hardness due to the squeezing out of oily liquid from
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the solid, especially at the relatively high liquid load. It is,
therefore, of interest to determine the tableting properties of
various silicates in presence of lipids and surfactants. In two
recent studies published in 2012, the tableting properties of
several silicates were investigated (16,17). Hentzschel et al. (16)
measured the tensile strength of four silicates, namely, Aerosil,
Aerogel, Neusilin and Florite, as a function of compression
pressure to determine their suitability as tableting excipients.
It was observed that three of them, Aerogel, Neusilin and
Florite, had acceptable tablet hardness. However, only the
neat silicates or the mixtures of silicates with microcrystalline
cellulose (Avicel) were used in these studies and no lipids or
surfactants were added. Mura et al. (17) adsorbed a self-
microemulsifying formulation onto several silicates before de-
termining their tabletability. They observed that only one of
the silicate used, Neusilin® US2, had acceptable tableting
properties. The lipid-based formulation used in this study
consisted primarily of the mixture of a surfactant (47%) and
an organic solvent (47%), and the concentration of lipid
component was relatively low (6%).
The present study has been undertaken to compare six
commonly available silicates from different manufactures for
their tabletability after loading two medium chain lipids and
a surfactant individually. The two representative lipids,
Capmul® MCM EP (glycerol monocaprylocaprate) and
Captex® 355 EP/NF (caprylic/capric triglycerides), and the
surfactant, Cremophor® EL (PEG-35 castor oil), selected for
the present study are commonly used in the development of
SEDDS (18). To date, silicates are usually used in the devel-
opment of solid dosage forms as glidants to enhance
flowability of powders by reducing interparticular cohesion
and adhesion (19). Therefore, all the silicates used in the
present investigation were not necessarily manufactured and
marketed for the application of adsorbing liquids. However,
the focus of the present investigation has been the tabletability
of silicates after adsorption of lipids and surfactants and no
other application of the silicates was investigated. In addition
to studying tabletability, the surface structure and relative
particle sizes of the silicates, the nature of their pores and
how the liquids were absorbed and distributed within the
pores or at the surface were examined. This was done by the
scanning electron microscopic (SEM) analysis of each silicate,
with and without the loading of liquid. Such a SEM analysis
may be able to explain the effect of adsorbed lipids and
surfactants on the tabletability of different solid formulations.
MATERIALS AND METHODS
Materials
Two medium chain lipids, Capmul® MCM EP (glycerol
monocaprylocaprate ) and Captex® 355 EP/NF
(caprylic/capric triglycerides) were used. They were obtained
from ABITEC Corp., Columbus, OH, USA. The surfactant,
Cremophor® EL (PEG-35 castor oil) was obtained from
BASF, Tarrytown, NY, USA. Compositions of lipids and the
surfactant used and structures of their primary components
were reported earlier (18). Various silicates used, along with
names of their manufacturers, are listed in Table I. The micro-
crystalline cellulose NF (Vivapur® 112) was obtained from JRS
Pharma, Rosenberg, Germany.
Tableting of Silicates without Added Lipids
Most of the available silicates are inherently non-tabletable
(20) and, as shown in Table I, have very low bulk density. The
bulk density of Aerosil 200®, for example, was extremely low.
Therefore, the tabletability of different silicates used in this
study was compared by mixing them with 20% w/w micro-
crystalline cellulose NF (MCC). Since the same concentration
of microcrystalline cellulose was present with all silicates, the
determination of relative tabletability of different silicates was
possible.
Formulations weighing ca. 400 mg that contained 20%w/w
microcrystalline cellulose and 80% w/w silica were com-
pressed at 50, 150 and 250 MPa using 14 mm flat face
punches (Natoli Engineering, Saint Charles, MO, USA) on a
single punch Carver Press assembly (Carver Inc., Wabash, IN,
USA). Tablet hardness was determined using a PAH-01 hard-
ness tester (Pharma Alliance, Valencia, CA, USA). Tablet
dimensions were then used to calculate the tensile strengths
(ρ) of the tablets using the following equation:
ρ ¼ 2F=πDT
where F is the breaking force, D and T are the diameter and
thickness, respectively (21). Since the hardness of tablets as
determined by the hardness tester varies depending on the
tablet size, the calculation of tensile strength in this way
normalized the size difference.
Liquid Loading onto Silicates
Initially, attempts were made to incorporate the lipids and the
surfactant with silicates bymixing the liquids and the silicates at
1:1 ratios in beakers with the help of a spatula or by levigating
them with a mortar and a pestle. However, the process was
unable to distribute lipids uniformly in some of the silicates and
the powders produced in several cases resulted into lumps with
poor flow properties. In several studies reported in the
literature, the lipid-based formulations were adsorbed
onto solid carriers by first dissolving them in volatile organic
solvents and then adding dry carrier powders to these solu-
tions, which was followed by drying of the mixtures (22,23). A
similar method was adopted in the present study for screening




























































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































3172 Gumaste et al.
various silicates for their suitability as carriers for lipids and
surfactants. Capmul® MCM EP, Captex® 355 and
Chremophor® EL were dissolved separately in minimum
necessary amounts of isopropanol. Silicates were then added
to the alcoholic solution to produce slurries such that the
silicate to lipid (or surfactant) ratio was 1:1 w/w. The slurries
were dried by placing them on open petri dishes at room
temperature in a fume hood for 2 days. The materials were
mixed intermittently with a spatula to facilitate drying. Free-
flowing and lump-free powders were obtained. It was con-
firmed by weighing the powders after drying that there was
a complete evaporation of isopropanol. The powders were
then passed through a sieve of 800-μmpore size before further
use.
Tableting of Liquid-Loaded Powders
Formulations containing approximately 50% w/w silicate
and 50% w/w lipid or surfactant and weighing ca.
800 mg were compressed at pressures ranging from
45 MPa to 270 MPa using 14 mm flat face punches
(Natoli Engineering) on a single punch Carver Press
assembly (Carver Inc.). No microcrystalline cellulose was
added with the liquid-loaded silicates as it was found that
some of the neat silicates could be compressed into hard
tablets even without adding microcrystalline cellulose and
the primary purpose of these experiments was to deter-
mine what effects the adsorbed liquids would have on the
tabletability of silicates. Tablet tensile strength was calcu-
lated as described earlier.
Scanning Electron Microscopy (SEM)
Preparation of Samples
The SEM study was conducted for the neat silicates as well as
for the silicate-liquid mixtures. Since the two lipids and the
surfactant used behaved similarly in the tableting study, only
one of them, Cremophor® EL, was used for the SEM study
of mixtures. Samples with the 1:1 w/w ratio of silicate and
Cremophor® EL was prepared for all silicates by the method
described earlier in this paper. Additionally, 1:2 and 1:3 w/w
ratios of silicate to Cremophor® EL was prepared for two of
the silicates (Neusilin® US2 and Neusilin® UFL2) that
showed promising tableting properties with the addition of
lipid or surfactant.
Recording of SEM Images
The samples were stored in closed vials prior to analysis.
SEM stubs were sterilized in acetone for 1 min, and then a
light dusting of each sample was adhered to the stub using
carbon tape. Next, the samples were platinum coated using
an EMS 550X sputter coater (ElectronMicroscopy Sciences,
Hatfield, PA, USA) at 25 mA. Most samples were coated for
~4 min; only a few samples were coated for ~2 min. The
samples were then observed under a variety of accelerating
voltages using a JEOL JSM-6010 analytical scanning elec-
tron microscope (JEOL Ltd, Tokyo, Japan). The micro-
graphs were digitally captured at 5 and 10 kV.
RESULTS AND DISCUSSION
Tabletability of Silicates without Liquid Adsorption
Tabletability may be defined as the capacity of a powder to
be transformed into a tablet of specified strength under the
effect of a certain compaction pressure (24). It is typically
characterized by plotting tablet tensile strength as a function
of compaction pressure.
Table II shows the tabletability profiles of the selected
silicates in presence of 20% MCC. To obtain a preliminary
insight into the tabletability behavior of these formulations,
three compaction pressures (viz. 50 MPa, 150 MPa and
200MPa) representing a relatively wide range of compaction
behavior were utilized. Tensile strength values in excess of
1 MPa are typically desired for tablets to withstand stress
during their lifetime (25). Among the silicates tested, only
Neusilin® US2 and Neusilin® UFL2 could produce
tablets with a tensile strength of ≥1 MPa under all three
compression pressures used, while Zeopharm® 600
exhibited high tensile strengths at compression pressures
of 150 and 250 MPa, which were comparable to that of
Neusilin® US2 and Neusilin® UFL2. Sipernat® 22
could produce a tensile strength of 1.2 MPa at a com-
paction pressure of 250 MPa; however, the value was
about one-fourth of that produced by Zeopharm® 600,
Neusilin® UFL2 and Neusilin® US2. Aerosil® 200 and
Sylysia 350® produced tablets of poor tensile strength,
Table II Tabletability (Tensile Strength in MPa) of Selected Silicates Blended
with 20% w/w MCC (Average of 2 Determinations)
Silicate used (+20% w/w
microcrystalline cellulose)
Tensile strength (MPa) at different
compression pressure
50 MPaa 150 MPaa 250 MPaa
Aerosil® 200 0.1 0.4 Broken
Neusilin® UFL2 1.4 4.4 5.0
Neusilin® US2 1.2 5.3 4.6
Sipernat® 22 Broken 0.6 1.2
Sylysia® 350 0.1 0.9 Laminated
Zeopharm® 600 0.6 5.5 5.0
a Compression pressure
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which broke or laminated at high pressure. Formulations of
Aerosil® 200 and Sylysia 350® were also very difficult
to handle due to low bulk density of materials and the
tendency to form aggregates. Since very high tablet
tensile strengths (> 5 MPa) could be obtained with some
of the formulations at merely 20% MCC load, addition
of MCC at higher concentrations was not considered
to be important in comparing tableting properties of
different silicates.
Tabletability of Silicates in Presence of Lipids
and Surfactant
Since Neusilin® US2, Neusilin® UFL2 and Zeopharm®
600 exhibited acceptable tableting properties when used
without the adsorption of liquids, it was of interest to deter-
mine how will they behave when lipids and surfactants are
adsorbed onto them. The tabletability of other three silicates
(Aerosil 200, Sipernet 22 and Sylysia 350) was also studied to
determine what effects the adsorbed lipids and surfactant
would have on their tabletability.
The results of the tabletability of various silicates in pres-
ence of Capmul® MCM, Captex® 355 and Cremophor®
EL are, respectively, shown in Fig. 1a, b and c. No microcrys-
talline cellulose was added in preparing these tablets. It is
evident from the figures that only Neusilin® US2 and
Neusilin® UFL2 could produce tablets with tensile strength
equivalent to or higher than 1MPa. The tablets obtained with
the other silicates were soft and oily, which often laminated or
capped and in some cases even stuck to the punches.
However, irrespective of such anomalies, all tablets were
analyzed for their tensile strengths and the values reported.
Between Neusilin®US2 andNeusilin®UFL2, the later could
produce acceptable tablets (~1 MPa) at the low pressures
45 MPa and its tabletability decreased at higher pressures.
Although Zeopharm® 600 produced excellent tablets in the
absence of liquid load where its tensile strengths were similar
to those of Neusilin® US2, it failed to produce acceptable
tablets in presence of adsorbed lipids and surfactant. Indeed,
the tabletability of Zeopharm® 600 in presence of the liquid
was very similar to that of the other silicates that did not
produce acceptable tablets without adsorbed liquids. It is,
therefore, evident from Fig. 1a, b and c that Neusilin® US2
outperformed all other silicates tested in the present investiga-
tion with respect to their tabletability. Neusilin® US2 did this
by exhibiting superior tensile strength at the 1:1 w/w loading
of lipids and surfactant. The appearance Neusilin® US2
tablets were also excellent, irrespective of the type of liquid
and the amount of compression pressure used, which ranged
from 45 to 270 MPa. The tabletability of Neusilin® US2,
however, decreased below the acceptable limit when the
liquid load was increased to 1:2 and 1:3 w/w (data not shown).
Using blends of a liquid, tocopherol acetate, and several
silicates, Hentzschel et al. (23) observed that, unlike most other
silicates, Neusilin® US2 exhibits good tabletability. Thus, the
results of the present investigation are also in agreement with
previous observations by other investigators.
Fig. 1 Tabletability of selected carriers at 1:1 w/w ratio with (a) glycerol
monocaprylocaprate (Capmul® MCM EP), (b) caprylic/capric triglyceride
(Captex® 355), and (c) PEG-35 castor oil (Cremophor® EL). Each data
point is the average of 2 separated determinations.
3174 Gumaste et al.
As shown in Tables I and II and also reported in the
literature (20), most silicates used in pharmaceutical products
exhibit very low bulk densities and lack inherent tabletability.
It was observed in the present study that there was a signif-
icant improvement in the densities of the silicates after load-
ing of liquids (data not shown). However, such an increase in
density did not have any positive impact on the tabletability
of silicates. Khan et al. (15,26) used additional excipients,
such as microcrystalline cellulose, to increase the tabletability
of silicates with adsorbed lipids and surfactants. Although
helpful, such addition of other excipients increases the tablet
weight and may, indeed, reduce the lipid and surfactant load
and hence the drug load in the tablet drastically, especially
when the drug solubility in the lipid is low or the dose is high.
For this reason, the 1:1 w/w ratio of the adsorbed liquid to
the silicate, without the addition of any tableting aid like
microcrystalline cellulose, was selected in the present study as
the initial acceptance criteria for the lipid-based tablet
formulations.
Figure 2 shows the effect of lipid and surfactant on the
tabletability of Neusilin® US2. Since Neusilin® US2 by
itself could also be compressed into tablets, the neat silicate
rather than its mixture with 20% w/w microcrystalline cel-
lulose was used for comparison with the ones containing two
lipids and one surfactant. As mentioned earlier, the
tabletability of Neusilin® US2 in presence of 1:1 w/w liquid
load was found to be acceptable (Fig. 1a, b and c). However,
the comparative data in Fig. 2 demonstrate that the
tabletability of Neusilin® US2 decreased drastically upon
the loading of liquids (ca. 6 MPa for neat silicate at the
compaction pressure of 135 MPa versus ca. 2 MPa in pres-
ence of liquid at the same pressure). The distinct loss of
tabletability in presence of lipid and surfactant could be
attributed to the interparticulate spreading of the liquid in
the tablet bed, thus interfering in the bonding between
silicate particles.
Effect of Type of Liquid Component on Tabletability
The physics of adsorption of liquid solutions of drugs onto
mesoporous substances like Neusilin® US2 was described
and reviewed by Qian and Bogner (7). Although the adsorp-
tion of liquids on silicates is expected to be a completely
physical process, it was of interest to see if there was any
effect of individual liquid components (Capmul® MCM EP,
Captex® 355 and Cremophor® EL) of lipid-based drug
delivery systems on the tabletability of the silicates. It may
be observed from Fig. 1a, b and c that there was no differ-
ence among the three liquids (two lipids and one surfactant)
used in the present study on their impact on tabletability of
silicates. If at all, the difference was marginal and not
significant.
Effect of Particle Size
The exact physicochemical basis of the good tabletability
exhibited by Neusilin® US2 is not known. It could possibly
be attributed to its chemical composition, relatively large
particle size and porous granular nature. To ascertain the
effect of particle size on the tabletability of Neusilin® US2,
Fig. 2 Comparative tabletability of Neusilin® US2 without and with
the liquid load. Data for neat Neusilin® US2 vs. Neusilin®US2
loaded with glycerol monocaprylocaprate (Capmul® MCM EP),
caprylic/capric triglyceride (Captex® 355) and PEG-35 castor oil at
1:1 w/w ratio are shown (n=1).
Fig. 3 Effect of particle size on the tabletability of Neusilin® US2 and
Neusilin® UFL2 loaded with Cremophor® EL at 1:1 w/w ratio and
compressed at 135 MPa. *UFL2 (5 μm) compressed at 45 MPa.
(n=3±s.d.)
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an experiment was conducted where Neusilin® US2 was
sieved through No. 120 (125 μm) and No. 325 (45 μm)
sieves. One of the liquids, Cremophor® EL, was then
adsorbed at the 1:1 w/w ratio onto the three sieve fractions
with high, intermediate and low particle sizes of Neusilin®
US2 (>125, 45–125 and <45 μm). As shown in Fig. 3, there
was no major difference in tensile strengths of the three
sieved fractions of Neusilin® US2 as the values ranged from
~1.6 to 2.1 MPa. The values were also essentially similar to
that of the non-sieved material.
Since the difference in the tensile strength of different
Neusilin® US2 particle fractions ranging from <45 μm to
>125 μm was only marginal, further investigation of the effect
of particle size on tabletability was conducted using Neusilin®
UFL2, which is compositionally similar to Neusilin® US2
(Table I) but had a much lower particle size (<5 μm). The results
are also given in Fig. 3, showing that at the 1:1 w/w ratio with the
liquids Neusilin® UFL2 exhibited poor tabletability having the
tensile strength of <1 MPa. These results presented in Fig. 3 are
in agreement with those observed in Fig. 1. Thus, it is apparent
Fig. 4 SEM images of neat Aerosil® 200 at 270× (a), 1500× (b) and 5500× (c) magnifications and 1:1 w/w mixture of Aerosil® 200 with PEG-35 castor
oil (Cremophor® EL) at 270× (d), 1500× (e) and 6000× (f) magnifications. A microscope scale is shown in each image for comparison of dimensions.
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that a relatively large difference in particle size of the same class of
silicates (for example, Neusilin® US2 vs. Neusilin® UFL2) can
influence the tabletability of material after adsorption of lipids
and surfactants. The relatively larger particle size of the same
class of silicates appears to favor the development of tablet
formulations for lipid-based drug delivery systems.
It is possible that when a liquid is loaded onto larger
Neusilin® US2 particles most of it is adsorbed deeper inside
the pores and, therefore, a relatively lesser amount covers the
particle surface. On the other hand, for smaller particles the
adsorbed liquid tends to stay closer to the surface of the particles
and they may be squeezed out more easily by the pressure
applied during tableting. As a result, the inter-particulate bond-
ing between the carrier particles of the later systems could be
heavily interfered by the presence of liquids. The decrease in
tabletability of Neusilin® UFL2 with smaller particle size may,
thus, be attributed to the liquids staying onto or closer to the
surface of such particles. It may also explain the decrease in
tensile strength with the increase in compression pressure ob-
served for Neusilin®UFL2 in Fig. 1a, b and c. It is possible that
Fig. 5 SEM images of neat Sylysia® 350 FCP at 1500× (a), 3700× (b) and 5500× (c) magnifications and 1:1 w/w mixture of Sylysia® 350 FCP with PEG-
35 Castor oil (Cremophor® EL) at 700× (d), 3000× (e) and 6000× (f) magnifications. A microscope scale is shown in each image for comparison of
dimensions.
Effect of Adsorbed Lipid and Surfactant on Different Silicates 3177
more of the liquid squeezed out of the pores at higher compres-
sion pressure, which decreased the tensile strength of tablets.
Unlike Neusilin® US2, tablets made up of Sipernat® 22
having an average particle size of 110 μm, which is essentially
similar to that of Neusilin® US2, exhibited poor tabletability
(tensile strengths <1MPa; Fig. 1a, b and c) when loaded at 1:1
ratio with Cremophor® EL. It is, therefore, evident that
certain properties of silicates other than particle size may also
influence the tablet development of lipid-based systems.
SEM Study
Although many different studies on the adsorption of lipids
and surfactants onto silicates were reported in the literature,
there is no systematic investigation on why certain silicates
exhibit acceptable tabletability while others do not. In the
present investigation, the surface structures of six different
silicates were studied, with and without the adsorption of a
liquid component, for an insight into their tabletability.
Although two lipids and one surfactant have been used in
compression studies, Fig. 1 shows that all of them have
similar effects on the tabletability of silicates. All three of
them also showed similar SEM micrographs when adsorbed
onto silicates. Therefore, the detailed SEM studies were
conducted using only PEG-35 castor oil (Cremophor® EL).
Aerosil® 200
Figure 4 shows the SEM micrographs of Aerosil® 200 as
neat material and after adsoption of Cremophor® EL at 1:1
w/w ratio. The depths of the microscopic fields give a three
dimensional perceptions of the SEM images. In the left hand
column of Fig. 4, the top image (Fig. 4a) shows the neat
material 270× magnification, which is then followed by the
images of the same material at 1500× and 5500× magnifi-
cations (Fig. 4b and c, respectively). Scales of 50, 10 and
2 μm are shown in Fig. 4a, b and c, respectively, for an
overview of the particle size of the material. It is apparent
that Aerosil® 200 exists as loose aggregates of very fine
particles. Even at the magnification of 5500× and the scale
of 2 μm (Fig. 4c), the material exhibits aggregation. These
results are in agreement with the description of Aerosil® 200
in Table I to be nanosized aggregates of silicon dioxide.
Unlike the neat material, Aerosil® 200 formed relatively
large granules when Cremophor® EL was adsorbed onto it
at 1:1 w/w ratio (Fig. 4d, e and f at, respectively, 270×,
1500× and 6000× magnifications). In contrast to the ex-
tremely fine nanosized particles of neat Aerosil® 200, the
granules are much larger than 50 μm and could be as large
as 300 μm (Fig. 4d). Further magnification of the surface of
the granules produced (Fig. 4e and f) show that they are
apparently held together by the liquid. Thus, the adsorbed
oily liquid is apparently acting as the granulating agent for
the Aerosil® 200 and is interspersed in between particles.
This might be the mechanism how the silicates work as
adsorption media for such liquids. Since particle size of
Aerosil® 200 is extremely low, any possibility of the existence
Fig. 6 SEM images of neat Zeopharm® 600 at 270× (a) and 2500× (b)
magnifications and after adsorption with 1:1 w/w PEG-35 castor oil
(Cremophor® EL) at 2200× (c) magnification. A microscope scale is
shown with each image for comparison.
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of sizable pores and the adsorption of lipids and surfactants
into such pores appear to be low. Aerosil® 200 is not inher-
ently tabletable. The presence of liquids at the surface of the
silicate rather than inside pores and the possibility of their
squeezing out under pressure from granules formed might
even add to its lack of tabletability.
Sylysia® 350
This silicate shows SEM micrographs very similar to those of
Aerosil® 200. The left hand column of Fig. 5 shows SEM
images of Sylysia® 350 at 1500×, 3700× and 5500× (Fig. 5a,
b and c, respectively) with the embedded measuring scales of
10, 5 and 2 μm, respectively. It is apparent from these images
that the material exists as loose aggregates of very fine parti-
cles. Even at the scale of 2 μm (Fig. 5c), the aggregates can be
distinctly observed, and the size of the individual particles
appear to be much less than 1 μm. Thus, the reported particle
size of 1.8 μm, as noted in Table I, seems to be higher than
what we observed in the SEM images.
Again, very similar to Aerosil® 200, Sylysia® 350 forms
granules in presence of Cremophor® EL at the 1:1 w/w
ratio (Fig. 5d, e and f at, respectively, 700×, 3000× and
6000× magnifications) and the liquid is distributed inside
as well as at the surface of the granules formed. Sylysia® 350
is inherently poorly tabletable, and the adsorption of oily
liquids onto the relatively large surface area of very small
particles would make the material even less tabletable.
Zeopharm® 600
Figure 6a and b give the SEM micrographs of neat
Zeopharm® 600 at 270× and 2500× magnifications. The
reported particle size of Zeopharm® is 6 μm (Table I).
However, at the scale of 10 μm in Fig. 6b, the material appears
to be agglomerates of very fine particles and even the size of the
agglomerates appears to be much less than 6 μm. It appears
that the size of individual particles would be less than 1 μm and
thus the particle size of Zeopharm® appears to be closer to
those of Aerosil® 200 and Sylysia® 350. It is evident that like
Aerosil® 200 and Sylysia® 350, Cremophor® EL is distribut-
ed on the surface of Zeopharm® 600 after adsorption (Fig. 6c),
which is responsible for the poor tabletability observed.
Sipernat® 22
It is a precipitated silica with the reported particle size of
120 μm (Table I). The left hand column of Fig. 7 shows the
Fig. 7 SEM images of neat Sipernat® 22 at 700× (a) and 2500× (b) magnifications and after adsorption of 1:1 w/w PEG-35 castor oil (Cremophor® EL) at
1200× (c) and 4300× (d) magnifications. Scales of individual images are shown for comparison.
Effect of Adsorbed Lipid and Surfactant on Different Silicates 3179
surface of Sipernat® 22 at 700× and 2500× (Fig. 7a and b,
respectively), while the right hand column of the figure depicts
the surface of the material at 1200× and 4300× (Fig. 7c and d,
respectively) after the adsorption of Cremophor® EL at 1:1
w/w ratio. The particles appeared to be rigid with a relatively
smooth surface and, unlike Neusilin® US2 discussed below,
no relatively large pores were visible. When Cremophor® EL
was adsorbed onto Sipernat® 22, it was inferred from the
SEM pictures that the liquid might have formed a layer at the
surface. The rigidity of the particles and the spreading of oily
liquids at the surface of individual particles could be the
possible reasons for poor tabletability of Sipernat® 22 before
and after adsorption of Cremophor® EL.
Neusilin® US2
The SEM micrographs of neat Neusilin® US2 at 1000×,
2300× and 5500× magnifications are shown in the left
column of Fig. 8a, b and c, respectively. It is clearly evident
from these figures that Neusilin® US2 is a granular and
Fig. 8 SEM images of neat Neusilin® US2 at 1000× (a), 2300× (b) and 5500× (c) magnifications and 1:1 w/w mixture of Neusilin® US2 with PEG-35
castor oil (Cremophor® EL) at 1000× (d), 3000× (e) and 6500× (f) magnifications. Microscope scales are shown with the images for comparison of
dimensions.
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highly porous material with relatively large pores. Figure 8c
indicates that the pore size could be as large as 1 μm in
diameter. However, Neusilin® US2 has been reported in the
literature to be mesoporous (7). According to the IUPAC
(International Union of Pure and Applied Chemistry) guide-
lines, mesoporous materials have pores in the range of 2–
50 nm, while the pore size is <2 nm for microporous materials
and >50 nm for macroporous materials (7). Because of the
small size, any micro- and meso-pores present in Neusilin®
US2 would not be visible under SEM, and, therefore, the
large pores observed in Fig. 8a, b and c indicate that
Neusilin® US2 is also highly macroporous.
The macropores were still visible when Cremophor® EL
was adsorbed onto Neusilin® US2 (Fig. 8d, e and f). Thus, it
appears that most of the oily liquid was adsorbed into
mesopores and deep into the channels of macropores of the
silicate. A comparison of the SEM micrographs on the right
hand side versus the left hand side column of Fig. 8 indicates
that the liquid might have also partially spread on the surface
of particles. There was only the partial spreading of liquid at
Fig. 9 SEM images of Neusilin® US2 loaded with 1:2 w/w PEG-35 castor oil (Cremophor® EL) at 450× (a), 950× (b) and 4000× (c) magnifications and
loaded with 1:3 w/w Cremophor® EL at 500× (d), 1000× (e) and 3300× (f) magnifications. Microscopic scales are shown with the images for comparison.
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the surface of Neusilin® US2, the remaining being adsorbed
within meso- and macro-pores below the surface. This may
possibly explain why Neusilin® US2 lost tabletability only
partially and still maintained acceptable tableting properties
in comparison with other silicates where most of the liquid
adsorbed on the surface.
As noted in Table I, Neusilin® US2 is a granular sub-
stance, and it is possible that its porosity is due to relatively
large channels formed within the granules. Figure 9 shows
the effect of increasing Cremophor® EL content of the
mixture on the surface of the silicate. When two parts of
Cremophor® EL was mixed with 1 part of Neusilin® US2
(w/w), the liquid covered most of the pores and appeared to
have also been deposited on the surface of the silicate
(Fig. 9a, b and c at, respectively, 450×, 950× and 4000×
magnifications). Further covering of the surface by
Cremophor® EL is evident when its concentration was
increased to 1:3 w/w (Fig. 9d, e and f at, respectively,
500×, 1000× and 3300× magnifications). Although mate-
rials at 1:2 and 1:3 silicate to surfactant ratios were still
Fig. 10 SEM images of neat Neusilin® UFL2 at 270× (a), 1000× (b) and 6500× (c) magnifications and 1:1 w/w mixture of Neusilin® UFL2 with PEG-35
castor oil (Cremophor® EL) at 270× (d), 1500× (e) and 8000× (f) magnifications. Microscope scales are shown with the images for comparison of
dimensions.
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powders, they were, however, not tabletable due the pres-
ence of oily liquid at the surface that hindered inter-
particulate bonding.
Neusilin® UFL2
Neusilin® UFL2 has similar chemical composition to that of
Neusilin® US2; however, it reportedly has low particle size
(Table I). The left hand column of Fig. 10 shows the SEM
images of neat Neusilin® UFL2 at 270×, 1000× and 6500×
magnifications (Fig. 10a, b and c, respectively). The material
is composed of the agglomerates of very fine particles. Even
at the scale of 2 μm, it appears to be agglomerates (Fig. 10c)
and, thus, it appears that the size of individual particles in
Neusilin® UFL2 is in the submicron range (<1 μm). With
the addition of Cremophor® EL at 1:1 w/w ratio, it
appeared that the liquid was adsorbed within the mesopores
and macropores of the silicate, and, therefore, the material
appeared to remain as fine particles (Fig. 10d, e and f). A
close comparison between Fig. 10b and e indicates that there
was also some agglomeration of powders, possibly because of
the surface adsorption of liquid. Upon further increase of
Neusilin® UFL2 to Cremophor® EL ratios to 1:2 and 1:3
w/w, the granulation progressed with the inter-particulate
distribution of the liquid. Due to such an adsorption of oily
liquids at the surface of and in between particles (Fig. 11),
Neusilin® UFL2 does not demonstrate acceptable
tabletability in presence of liquids (Fig. 1).
CONCLUSIONS
Although silicates are commonly used in the pharmaceutical
dosage form development as glidants, there has been a recent
interest in its application as adsorbents for the development
of solid dosage forms of liquid lipid-based drug delivery
systems. However, no systematic study has been conducted
on whether various silicates available for pharmaceutical
application are tabletable or not, whether the liquids are
adsorbed on the surface or inside the pores of silicates, and
what influence the adsoption of liquids have on their
tabletability. Among the six silicates studied in the present
investigation, three (Aerosil® 200, Sipernat® 22 and
Sylysia® 350) were primarily composed of silicon dioxide
and, when compressed in presence of 20% w/w microcrys-
talline cellulose, all of them were found to be non-tabletable
as the tablets did not achieve a minimum tensile strength of
1 MPa at the wide range of compression pressure used. The
Fig. 11 SEM images of Neusilin® UFL2 loaded with 1:2 w/w PEG-35 castor oil (Cremophor® EL) at 700× (a) and 2300× (b) magnifications and loaded
with 1:3 w/w Cremophor® EL at 650× (c) and 2500× (d) magnifications. Microscopic scales are shown with the images for comparison.
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adsorption of three different liquid components of lipid
based drug delivery systems, namely, Capmul®MCM (glyc-
erol monocaprylocaprate), Captex® 355 (caprylic/capric
triglycerides) and Cremophor® EL (PEG-35 castor oil), at
1:1 w/w ratios showed that the mixtures still remained
powders and their tabletability further decreased. The
SEM images of mixtures with one of these liquids
(Cremophor® EL) indicated that the adsorbed liquid
remained primarily at the surface of particles rather than
inside any pores and, as a result, the particles did not com-
pact into tablets. Zeopharm® 600, another silicate used in
the present investigation, is reported to contain calcium
oxide (24% w/w) along with silicon dioxide (57% w/w)
and it demonstrated good tabletability in absence of any
adsorbed liquid. However, when Cremophor EL was
adsorbed onto it at 1:1 w/w ratio, it lost its tabletability since
the SEM micrographs demonstrated that the liquid was
adsorbed onto the surface of solid particles creating inter-
particulate barriers in physical bonding during compression.
Neusilin® US2 and Neusilin® UFL2, which are the
remaining two silicates used in the present investigation,
are chemically similar containing mixtures of aluminum
oxide (32%), magnesium oxide (12%) and silicon dioxide
(32%). Both of them showed acceptable tabletability when
compressed without the addition of a liquid lipid or surfac-
tant. However, when Cremophor® EL was adsorbed onto
these materials at 1:1 w/w, only Neusilin® US2 could retain
acceptable tabletability while Neusilin® UFL2 demonstrated
minimally acceptable tabletability only at a low compression
pressure of 45 MPa and it failed to demonstrate acceptable
tabletability when the compression pressure was increased.
These results could be explained by the SEM photomicro-
graphs, which showed that the liquid was adsorbed into the
pores of relatively large particles of Neusilin® US2, while in
case of Neusilin® UFL2 the liquid was distributed at the
surface.
From the above summary, a trend appears in the mech-
anism of tabletability of different silicates. The silicates used
in the present study can be divided into two chemical groups:
one containing 98–100% silicon dioxide (Aerosil® 200,
Sipernat® 22 and Sylysia® 350), and the other containing
much lesser amount of silicon dioxide (32–57%), the rest
being aluminum oxide, magnesium oxide or calcium oxide
(Neusilin US2, Neusilin UFL2 and Zeopharm 600). In the
absence of adsorbed liquids, the second group was
tabletable, while the first was not. Thus, the chemical com-
position plays a major role in the tabletability of silicates.
Since there were big differences in particle sizes of Neusilin®
US2, Neusilin® UFL2 and Zeopharm® 600 , it appeared
that the particle size did not have major influence on the
tabletability of silicates in the absence of adsorbed liquids .
However, whether these silicates would retain their
tabletability after adsorption of liquids appears to be
dependent on particle size and possibly porosity. This is
evident from the greater loss of tabletability of Neusilin®
UFL2 and Zeopharm® 600 (silicates with lower particle size)
than that of Neusilin® US2 (silicate with larger particle size).
The porosity might be important as the porous channels
could be deeper in larger particles to retain the adsorbed
lipids during compression. Further studies are, however,
needed to elucidate mechanisms of why and how the chem-
ical composition influences the tabletability of silicates and
the effect of particle size and porosity on the tabletability
after the adsorption of lipidic materials.
It may be concluded that, among all the silicates used in
the present investigation, only Neusilin® US2 has both the
surface morphology and the porosity for use as the carrier in
the development of tablet formulations of lipid-based drug
delivery systems. The amount of liquid lipidic materials used
should, however, be limited. When the ratio of Neusilin®
US to the liquid was 1:1 w/w, there was acceptable
tabletability, and it decreased below the acceptable limit
when the liquid component was increased to 1:2 and 1:3
w/w ratios. It is hoped that the systematic approach adopted
in the present investigation will help the selection of silicates
from those currently available commercially. It may also
provide guidance for the synthesis of newer silicates for the
development of tablets containing lipid components.
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